Chemed Corporation (CHE) Misses Q4 EPS by 13c

Chemed Corporation (NYSE: CHE) reported Q4 EPS of $3.96, $0.13 worse than the analyst estimate of $4.09. Revenue for the quarter came in at $522 million versus the consensus estimate of $524.19 million.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c